Androgenisation of female partners of men on medroxyprogesterone acetate/percutaneous testosterone contraception.
D003075:Coitus; D003272:Contraceptive Agents, Male / Q000009:adverse effects*; D005260:Female; D006628:Hirsutism / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000009:adverse effects*; D013739:Testosterone / Q000008:administration & dosage / Q000009:adverse effects*
D003272:Contraceptive Agents, Male; D013739:Testosterone; D008525:Medroxyprogesterone